QCZ484

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QCZ484, covering 2025-12-04 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. [Phase 2]